Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,079 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: Increasing access to screening for blood-borne viruses and sexually transmissible infections for Aboriginal and Torres Strait Islander Australians: evaluation of the Deadly Liver Mob program's 'cascade of care' across nine sites in New South Wales, Australia.
Cama E, Beadman K, Beadman M, Smith KA, Christian J, Jackson AC, Tyson B, Anderson C, Smyth L, Heslop J, Gahan G, Tawil V, Sheaves F, Maher L, Page J, Tilley D, Ryan A, Grant K, Donovan B, Stevens A, Slattery T, Pearce K, John-Leader F, Walden A, Lenton J, Crowley M, Treloar C. Cama E, et al. Among authors: stevens a. Harm Reduct J. 2024 Feb 7;21(1):34. doi: 10.1186/s12954-024-00927-w. Harm Reduct J. 2024. PMID: 38326826 Free PMC article. No abstract available.
Increasing access to screening for blood-borne viruses and sexually transmissible infections for Aboriginal and Torres Strait Islander Australians: evaluation of the Deadly Liver Mob program's 'cascade of care' across nine sites in New South Wales, Australia.
Cama E, Beadman K, Beadman M, Smith KA, Christian J, Jackson AC, Tyson B, Anderson C, Smyth L, Heslop J, Gahan G, Tawil V, Sheaves F, Maher L, Page J, Tilley D, Ryan A, Grant K, Donovan B, Stevens A, Slattery T, Pearce K, John-Leader F, Walden A, Lenton J, Crowley M, Treloar C. Cama E, et al. Among authors: stevens a. Harm Reduct J. 2023 Sep 5;20(1):125. doi: 10.1186/s12954-023-00850-6. Harm Reduct J. 2023. PMID: 37670361 Free PMC article.
Evaluating a complex health promotion program to reduce hepatitis C among Aboriginal and Torres Strait Islander peoples in New South Wales, Australia: the Deadly Liver Mob.
Treloar C, Beadman K, Beadman M, Smith KA, Christian J, Jackson AC, Tyson B, Anderson C, Smyth L, Walker M, Heslop J, Gahan G, Tawil V, Sheaves F, Maher L, Page J, Tilley D, Ryan A, Grant K, Donovan B, Stevens A, Slattery T, Pearce K, John-Leader F, Walden A, Lenton J, Crowley M, Cama E. Treloar C, et al. Among authors: stevens a. Harm Reduct J. 2023 Oct 20;20(1):153. doi: 10.1186/s12954-023-00885-9. Harm Reduct J. 2023. PMID: 37864234 Free PMC article.
Incidence of hepatitis C virus infection in the prison setting: The SToP-C study.
Hajarizadeh B, Carson JM, Byrne M, Grebely J, Cunningham E, Amin J, Vickerman P, Martin NK, Treloar C, Martinello M, Lloyd AR, Dore GJ; SToP-C study group. Hajarizadeh B, et al. J Viral Hepat. 2024 Jan;31(1):21-34. doi: 10.1111/jvh.13895. Epub 2023 Nov 7. J Viral Hepat. 2024. PMID: 37936544 Free PMC article.
Hepatitis C Virus Reinfection Following Direct-Acting Antiviral Treatment in the Prison Setting: The SToP-C Study.
Carson JM, Dore GJ, Lloyd AR, Grebely J, Byrne M, Cunningham E, Amin J, Vickerman P, Martin NK, Treloar C, Martinello M, Matthews GV, Hajarizadeh B; Surveillance and Treatment of Prisoners With Hepatitis C (SToP-C) Study Group. Carson JM, et al. Clin Infect Dis. 2022 Nov 14;75(10):1809-1819. doi: 10.1093/cid/ciac246. Clin Infect Dis. 2022. PMID: 35362522
Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study.
Hajarizadeh B, Grebely J, Byrne M, Marks P, Amin J, McManus H, Butler T, Cunningham EB, Vickerman P, Martin NK, McHutchison JG, Brainard DM, Treloar C, Chambers GM, Grant L, Mcgrath C, Lloyd AR, Dore GJ; SToP-C study group. Hajarizadeh B, et al. Lancet Gastroenterol Hepatol. 2021 Jul;6(7):533-546. doi: 10.1016/S2468-1253(21)00077-7. Epub 2021 May 7. Lancet Gastroenterol Hepatol. 2021. PMID: 33965006
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study.
Valerio H, Alavi M, Conway A, Silk D, Treloar C, Martinello M, Milat A, Dunlop A, Murray C, Henderson C, Amin J, Read P, Marks P, Degenhardt L, Stevens A, Prain B, Hayllar J, Reid D, Montebello M, Wade A, Christmass M, Cock V, Dore GJ, Grebely J; ETHOS Engage Study Group. Valerio H, et al. Among authors: stevens a. Int J Drug Policy. 2022 Jul;105:103706. doi: 10.1016/j.drugpo.2022.103706. Epub 2022 May 6. Int J Drug Policy. 2022. PMID: 35533635
Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot Study.
Conway A, Stevens A, Murray C, Prain B, Power C, McNulty A, Carrington N, Lu H, Kingsland M, McGrath C, Read P, Starr M, Catlett B, Cunningham P, Grebely J. Conway A, et al. Among authors: stevens a. Open Forum Infect Dis. 2023 Oct 20;10(11):ofad517. doi: 10.1093/ofid/ofad517. eCollection 2023 Nov. Open Forum Infect Dis. 2023. PMID: 38023551 Free PMC article.
Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot.
Carrington N, Conway A, Grebely J, Starr M, Catlett B, Stevens A, Prain B, McGrath C, Causer L, Guy R, Holden J, Keen P, Kingsland M, Lu H, Power C, Read P, Murray C, McNulty A, Cunningham P; NSW DBS Pilot Study Group. Carrington N, et al. Among authors: stevens a. BMC Infect Dis. 2024 Jan 29;24(1):137. doi: 10.1186/s12879-024-08989-8. BMC Infect Dis. 2024. PMID: 38287234 Free PMC article.
2,079 results